Pulmonx
Kevin DeMartini is an experienced quality engineering professional with a comprehensive background in the medical device industry. Currently serving as Quality Engineering Manager at Pulmonx Corporation since September 2019, Kevin has previously held positions such as Senior Quality Engineer and Quality Engineer at BioCardia, Inc., where responsibilities included corrective/preventive actions, internal audits, process monitoring, and compliance with ISO 13485 and FDA regulations. Earlier, Kevin contributed as a Quality Engineering Intern and Assistant Equipment Manager at Consolidated Engineering Laboratories, demonstrating skills in equipment calibration and inventory management. Kevin holds a Bachelor of Science degree in Mechanical Engineering from Santa Clara University.
This person is not in any teams
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1